当前位置: 首页 > 期刊 > 《中国医药科学》 > 2022年第9期
编号:113370
胰腺癌免疫治疗的研究进展
http://www.100md.com 2022年7月13日 中国医药科学 2022年第9期
     苏祥杰 彭勇

    [摘要]胰腺癌是一种较为常见的消化系统肿瘤,恶性程度极高。由于胰腺癌发病隐匿,缺乏有效的早期诊断方法,确诊时大部分患者已为中晚期,错过了最佳手术时机。而针对中晚期胰腺癌,目前尚缺乏有效的治疗方案。要改善胰腺癌的治疗现状,不能仅靠手术治疗,化疗、免疫治疗及靶向治疗同样重要。近年来,免疫治疗在多种恶性肿瘤的治疗中取得重大进展,在胰腺癌的治疗中也有所突破。本文对近年来胰腺癌免疫治疗的研究进展做一概述,展示胰腺癌免疫治疗领域的研究进展。

    [关键词]胰腺癌;肿瘤微环境;免疫治疗;免疫检查点抑制剂;肿瘤疫苗

    [中图分类号] R735.9? [文献标识码] A? [文章编号]2095-0616(2022)09-0045-05

    Advances in the study of immunotherapy for pancreatic cancer SU? Xiangjie ?PENG? Yong2

    1.North Sichuan Medical College, Sichuan, Nanchong 637000, China;2.Department of Hepatobiliary-Pancreatic- Splenic Surgery, the Nanchong Central Hospital, Sichuan, Nanchong 637000, China

    [Abstract] Pancreatic cancer is a relatively common tumor of the digestive system with a high degree of malignancy . Due to the? insidious onset of pancreatic? cancer and the lack of effective? early diagnosis means, most patients are already in the middle and late stages when diagnosed, which causes the loss of the best time for surgery . There is a lack of effective treatment schemes for middle - and late -stage pancreatic cancer . Surgery cannot be the only way to improve the treatment status of pancreatic cancer ......

您现在查看是摘要页,全文长 16539 字符